A phase III randomized trial of chemoimmunotherapy comprising gemcitabine and capecitabine with or without telomerase vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer.

被引：0
|
作者：
Middleton, Gary William
Valle, Juan W.
Wadsley, Jonathan
Propper, David
Coxon, Fareeda Y.
Ross, Paul J.
Madhusudan, Srinivasan
Roques, Tom
Cunningham, David
Corrie, Philippa
Greenhalf, William
Shaw, Victoria
Cox, Trevor F.
Silcocks, Paul
Nanson, Gemma
Neoptolemos, John P.
机构：
[1] Univ Birmingham, Birmingham, W Midlands, England
[2] Christie Hosp NHS Fdn Trust, European ENETS Ctr Excellence, Manchester, Lancs, England
[3] Weston Pk Hosp, Dept Clin Oncol, Sheffield, S Yorkshire, England
[4] St Bartholomews Hosp, Inst Canc, Ctr Med Oncol, London, England
[5] Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, England
[6] Guys & St Thomas NHS Fdn Trust, London, England
[7] Univ Nottingham Hosp, Sch Mol Med Sci, Nottingham NG7 2UH, England
[8] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England
[9] Royal Marsden Hosp NHS Fdn Trust, London, England
[10] Addenbrookes Hosp, Ctr Oncol, Cambridge, England
[11] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA4004
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer
    Heinemann, Volker
    Quietzsch, Detlef
    Gieseler, Frank
    Gonnermann, Michael
    Schoenekaes, Herbert
    Rost, Andreas
    Neuhaus, Horst
    Haag, Caroline
    Clemens, Michael
    Heinrich, Bernard
    Vehling-Kaiser, Ursula
    Fuchs, Martin
    Fleckenstein, Doris
    Gesierich, Wolfgang
    Uthgenannt, Dirk
    Einsele, Hermann
    Holstege, Axel
    Hinke, Axel
    Schalhorn, Andreas
    Wilkowski, Ralf
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) : 3946 - 3952
  • [32] Phase I trial of capecitabine and gemcitabine with concurrent radical radiotherapy in locally advanced pancreatic cancer: final results
    Michael, M.
    Price, T.
    Leong, T.
    Ganju, V.
    Strickland, A.
    Jefford, M.
    Ngan, S.
    Milner, A.
    Zalcberg, J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 272 - 272
  • [33] Randomized controlled trial of gemcitabine in combination with UFT versus gemcitabine alone in patients with advanced pancreatic cancer.
    Ohkawa, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 346S - 346S
  • [34] Phase I trial of capecitabine and gemcitabine with concurrent radical radiotherapy in locally advanced pancreatic cancer: interim results
    Leong, T.
    Michael, M.
    Ganju, V.
    Price, T.
    Strickland, A.
    Jefford, M.
    Ngan, S.
    Zalcberg, J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 222 - 222
  • [35] Phase II trial of capecitabine and docetaxel as second line therapy for locally advanced and metastatic pancreatic cancer
    Blaya, M.
    Lopes, G. L., Jr.
    Roman, E.
    Ahn, E.
    Macintyre, J.
    Quesada, J.
    Levi, J.
    Walker, G.
    Green, M.
    Lima, C. M. Rocha
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Preliminary results of a phase II trial of irinotecan (I) and gemcitabine (G) in patients with locally advanced or metastatic bladder cancer.
    Chaudhary, U
    Shannon, S
    Curry, N
    Keane, TE
    Means, RT
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (01) : S293 - S293
  • [37] BAYPAN study: A double-blind, phase III randomized trial of gemcitabine plus sorafenib versus gemcitabine plus placebo in patients with advanced pancreatic cancer.
    Goncalves, A.
    Viret, F.
    Francois, E.
    Dahan, L.
    Perrier, H.
    Lamy, R.
    Re, D.
    Largillier, R.
    Gasmi, M.
    Tchiknavorian, X.
    Turrini, O.
    Moureau-Zabotto, L.
    Delpero, J.
    Viens, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [38] Phase I/II trial of carbon-ion radiotherapy with concurrent gemcitabine for patients with locally advanced pancreatic cancer.
    Shinoto, Makoto
    Yamada, Shigeru
    Yasuda, Shigeo
    Imada, Hiroshi
    Shioyama, Yoshiyuki
    Honda, Hiroshi
    Kamada, Tadashi
    Tsujii, Hirohiko
    Saisho, Hiromitsu
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial
    Jung Hyun Jo
    Yong-Tae Kim
    Ho Soon Choi
    Ho Gak Kim
    Hong Sik Lee
    Young Woo Choi
    Dong Uk Kim
    Kwang Hyuck Lee
    Eui Joo Kim
    Joung-Ho Han
    Seung Ok Lee
    Chang-Hwan Park
    Eun Kwang Choi
    Jae Woo Kim
    Jae Yong Cho
    Woo Jin Lee
    Hyungsik Roger Moon
    Mi-Suk Park
    Sangjae Kim
    Si Young Song
    British Journal of Cancer, 2024, 130 : 163 - 163
  • [40] Phase two clinical trial of combination oxaliplatin, irinotecan, and cetuximab for patients with locally advanced or metastatic pancreatic cancer.
    Abdou, Yara
    Friend, Sarah Cooke
    Patt, Yehuda Z.
    Gan, Christine
    Lee, Fa-Chyi
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345